AMY ROUSSEAU: Open Payments
NPI 1962023630 · LEWISTON ME, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 55 payments from 21 companies in 2025. Trend: 2023 $473 · 2024 $1,243 · 2025 $1,119
Food & beverage: $1,119
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $208 |
| ABBVIE INC. | 5 | $145 |
| Amgen Inc. | 6 | $113 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| PFIZER INC. | 4 | $81 |
| Novo Nordisk Inc | 4 | $73 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $40 |
| Lundbeck LLC | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $38 |
Products named: BREZTRI, VRAYLAR, EVENITY, OTEZLA, Auvelity, AIRSUPRA, SHINGRIX, REXULTI.
Industry payments across ME — which companies pay providers there.
